Vecprobio
UEI: VES5VBS3VM25
• CAGE: 94ZY9
• DBA: CIRSIUM BIOSCIENCES
Overview
Awardee Type
Parent
Company Description
Cirsium Biosciences is democratizing gene therapy through transformative viral vector production methods and systems.
Name
Vecprobio
Website
Headquarters
San Diego, CA
United States
United States
Most Recent Award
Sept. 17, 2024
Calculating
Federal contract recipient
VECPROBIO INC
dba CIRSIUM BIOSCIENCES
(UEI VES5VBS3VM25, CAGE 94ZY9)
is headquartered in San Diego CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in May 2020 and
federally registered in
August 2021.
Federal Award Analysis
Vecprobio federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
VECPROBIO INC
DBA
CIRSIUM BIOSCIENCES
UEI
VES5VBS3VM25
CAGE Code
94ZY9
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
May 4, 2020
Initial Registration
Aug. 23, 2021
Last Registration
Sept. 9, 2024
Registration Activation
Sept. 9, 2024
Registration Expiration
Sept. 5, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
Not Available
Accepts Credit Cards
No